Загрузка...
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
Genetic deficiency of the nuclease DCLRE1C/Artemis causes radiosensitive severe combined immunodeficiency (RS-SCID) with lack of peripheral T and B cells and increased sensitivity to ionizing radiations. Gene therapy based on transplanting autologous gene-modified hematopoietic stem cells could sign...
Сохранить в:
| Опубликовано в: : | Mol Ther Methods Clin Dev |
|---|---|
| Главные авторы: | , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Gene & Cell Therapy
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6838972/ https://ncbi.nlm.nih.gov/pubmed/31720302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2019.08.014 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|